Los Angeles Capital Management Portfolio holdings
AUM
$26.7B
1-Year Return
35.08%
This Quarter Return
+14.69%
1 Year Return
+35.08%
3 Year Return
+164.18%
5 Year Return
+293.76%
10 Year Return
+832%
AUM
$26.8B
AUM Growth
+$3.21B
(+14%)
Cap. Flow
+$333M
Cap. Flow
% of AUM
1.24%
Top 10 Holdings %
Top 10 Hldgs %
33.69%
Holding
1,279
New
177
Increased
369
Reduced
457
Closed
160
Top Buys
| 1 |
Target
TGT
|
+$173M |
| 2 |
Starbucks
SBUX
|
+$159M |
| 3 |
Amgen
AMGN
|
+$150M |
| 4 |
Ross Stores
ROST
|
+$133M |
| 5 |
3M
MMM
|
+$121M |
Top Sells
| 1 |
Visa
V
|
+$130M |
| 2 |
Eli Lilly
LLY
|
+$110M |
| 3 |
Cisco
CSCO
|
+$107M |
| 4 |
Adobe
ADBE
|
+$102M |
| 5 |
Newmont
NEM
|
+$101M |
Sector Composition
| 1 | Technology | 34.52% |
| 2 | Consumer Discretionary | 14.2% |
| 3 | Financials | 13.05% |
| 4 | Industrials | 10.11% |
| 5 | Communication Services | 9.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
976
Signet Jewelers
SIG
$3.76B
| $342K | ﹤0.01% |
+3,188
| New | +$342K |
|
977
Flex
FLEX
$21.5B
| $340K | ﹤0.01% |
14,825
| – | – |
|
978
Karyopharm Therapeutics
KPTI
$58.7M
| $339K | ﹤0.01% |
+26,103
| New | +$339K |
|
979
NeoGenomics
NEO
$1.06B
| $339K | ﹤0.01% |
20,925
-470
| -2% | -$7.61K |
|
980
WEX
WEX
$5.93B
| $337K | ﹤0.01% |
1,733
+72
| +4% | +$14K |
|
981
Olo Inc
OLO
$1.74B
| $337K | ﹤0.01% |
58,906
-39,538
| -40% | -$226K |
|
982
Coupang
CPNG
$59.2B
| $336K | ﹤0.01% |
20,783
-181,648
| -90% | -$2.94M |
|
983
ACV Auctions
ACVA
$1.74B
| $336K | ﹤0.01% |
22,150
-590
| -3% | -$8.94K |
|
984
Calix
CALX
$4.01B
| $334K | ﹤0.01% |
7,656
-568
| -7% | -$24.8K |
|
985
American Electric Power
AEP
$58.4B
| $333K | ﹤0.01% |
4,101
+125
| +3% | +$10.2K |
|
|
SAGE
986
DELISTED
Sage Therapeutics
SAGE
| $333K | ﹤0.01% |
+15,348
| New | +$333K |
|
|
BHR
987
Braemar Hotels & Resorts
BHR
$201M
| $332K | ﹤0.01% |
132,980
| – | – |
|
|
KAMN
988
DELISTED
Kaman Corp
KAMN
| $330K | ﹤0.01% |
+13,788
| New | +$330K |
|
989
WEC Energy
WEC
$35.5B
| $329K | ﹤0.01% |
3,913
-6,218
| -61% | -$523K |
|
990
Stoke Therapeutics
STOK
$1.33B
| $327K | ﹤0.01% |
62,257
+14,510
| +30% | +$76.3K |
|
991
Wingstop
WING
$7.43B
| $327K | ﹤0.01% |
1,276
-4,706
| -79% | -$1.21M |
|
992
Idacorp
IDA
$6.81B
| $326K | ﹤0.01% |
3,316
-115
| -3% | -$11.3K |
|
993
Freeport-McMoran
FCX
$63.9B
| $324K | ﹤0.01% |
7,612
-164
| -2% | -$6.98K |
|
994
Standex International
SXI
$2.47B
| $323K | ﹤0.01% |
+2,040
| New | +$323K |
|
995
Perrigo
PRGO
$3.08B
| $322K | ﹤0.01% |
+10,020
| New | +$322K |
|
996
McKesson
MCK
$89.1B
| $322K | ﹤0.01% |
696
-3,046
| -81% | -$1.41M |
|
997
Rocky Brands
RCKY
$216M
| $322K | ﹤0.01% |
+10,677
| New | +$322K |
|
998
Inspire Medical Systems
INSP
$2.41B
| $322K | ﹤0.01% |
1,583
-53,609
| -97% | -$10.9M |
|
999
Twist Bioscience
TWST
$1.53B
| $321K | ﹤0.01% |
+8,713
| New | +$321K |
|
1000
BioCryst Pharmaceuticals
BCRX
$1.68B
| $319K | ﹤0.01% |
53,330
+20,202
| +61% | +$121K |
|